EE04643B1 - Osteoprotegeriin - Google Patents
OsteoprotegeriinInfo
- Publication number
- EE04643B1 EE04643B1 EE9700164A EE9700164A EE04643B1 EE 04643 B1 EE04643 B1 EE 04643B1 EE 9700164 A EE9700164 A EE 9700164A EE 9700164 A EE9700164 A EE 9700164A EE 04643 B1 EE04643 B1 EE 04643B1
- Authority
- EE
- Estonia
- Prior art keywords
- osteoprotegerin
- Prior art date
Links
- 102000008108 Osteoprotegerin Human genes 0.000 title 1
- 108010035042 Osteoprotegerin Proteins 0.000 title 1
- XXUPLYBCNPLTIW-UHFFFAOYSA-N octadec-7-ynoic acid Chemical compound CCCCCCCCCCC#CCCCCCC(O)=O XXUPLYBCNPLTIW-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/577,788 US6613544B1 (en) | 1995-12-22 | 1995-12-22 | Osteoprotegerin |
US08/706,945 US6369027B1 (en) | 1995-12-22 | 1996-09-03 | Osteoprotegerin |
PCT/US1996/020621 WO1997023614A1 (en) | 1995-12-22 | 1996-12-20 | Osteoprotegerin |
Publications (2)
Publication Number | Publication Date |
---|---|
EE9700164A EE9700164A (et) | 1998-02-16 |
EE04643B1 true EE04643B1 (et) | 2006-06-15 |
Family
ID=27077338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EE9700164A EE04643B1 (et) | 1995-12-22 | 1996-12-20 | Osteoprotegeriin |
Country Status (31)
Country | Link |
---|---|
US (1) | US6369027B1 (ko) |
EP (4) | EP1990415A1 (ko) |
JP (1) | JP4657388B2 (ko) |
KR (1) | KR100463584B1 (ko) |
CN (1) | CN1318588C (ko) |
AR (1) | AR004400A1 (ko) |
AT (1) | ATE409745T1 (ko) |
AU (1) | AU710587B2 (ko) |
BG (1) | BG63347B1 (ko) |
CA (1) | CA2210467C (ko) |
CZ (1) | CZ292587B6 (ko) |
DE (1) | DE19654610A1 (ko) |
DK (1) | DK0784093T3 (ko) |
EE (1) | EE04643B1 (ko) |
ES (1) | ES2316152T3 (ko) |
FR (1) | FR2742767B1 (ko) |
GB (1) | GB2312899B (ko) |
HK (1) | HK1001526A1 (ko) |
HU (1) | HU227482B1 (ko) |
IL (1) | IL121520A (ko) |
MX (1) | MX9706193A (ko) |
NO (1) | NO973699L (ko) |
NZ (2) | NZ332915A (ko) |
PL (1) | PL187408B1 (ko) |
PT (1) | PT784093E (ko) |
RO (1) | RO121386B1 (ko) |
SI (1) | SI0784093T1 (ko) |
SK (1) | SK110797A3 (ko) |
TR (1) | TR199601036A2 (ko) |
WO (1) | WO1997023614A1 (ko) |
YU (1) | YU69196A (ko) |
Families Citing this family (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6919434B1 (en) | 1995-02-20 | 2005-07-19 | Sankyo Co., Ltd. | Monoclonal antibodies that bind OCIF |
IL117175A (en) * | 1995-02-20 | 2005-11-20 | Sankyo Co | Osteoclastogenesis inhibitory factor protein |
US7078493B1 (en) | 1995-03-15 | 2006-07-18 | Human Genome Sciences, Inc. | Antibodies to human tumor necrosis factor receptor-like genes |
US7005413B1 (en) | 1995-12-22 | 2006-02-28 | Amgen Inc. | Combination therapy for conditions leading to bone loss |
US7632922B1 (en) * | 1995-12-22 | 2009-12-15 | Amgen, Inc. | Osteoprotegerin |
JPH1057071A (ja) * | 1996-08-19 | 1998-03-03 | Snow Brand Milk Prod Co Ltd | 新規dna及びそれを用いた蛋白質の製造方法 |
CA2273852C (en) | 1996-12-06 | 2009-09-29 | Amgen Inc. | Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases |
US6271349B1 (en) | 1996-12-23 | 2001-08-07 | Immunex Corporation | Receptor activator of NF-κB |
DE69740107D1 (de) | 1996-12-23 | 2011-03-10 | Immunex Corp | Rezeptor aktivator von nf-kappa b, rezeptor is mitglied der tnf rezeptor superfamilie |
NZ332995A (en) * | 1997-04-15 | 2000-07-28 | Snow Brand Milk Products Co Ltd | A protein which binds to osteoclastogenesis inhibitory factor (OCIF) |
ATE363533T1 (de) | 1997-04-16 | 2007-06-15 | Amgen Inc | Osteoprotegerin bindende proteine und rezeptoren |
US6316408B1 (en) | 1997-04-16 | 2001-11-13 | Amgen Inc. | Methods of use for osetoprotegerin binding protein receptors |
AU7469998A (en) * | 1997-05-01 | 1998-11-24 | Amgen, Inc. | Chimeric opg polypeptides |
WO1999004001A1 (en) * | 1997-07-21 | 1999-01-28 | Zymogenetics, Inc. | Tumor necrosis factor receptor ztnfr-5 |
EP1019502A2 (en) * | 1997-08-06 | 2000-07-19 | Regeneron Pharmaceuticals, Inc. | Human orphan receptor ntr-1 |
US6346388B1 (en) | 1997-08-13 | 2002-02-12 | Smithkline Beecham Corporation | Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2 |
WO1999011790A1 (en) * | 1997-09-04 | 1999-03-11 | Zymogenetics, Inc. | Tumor necrosis factor receptor ztnfr-6 |
DK1015587T3 (da) * | 1997-09-18 | 2008-08-25 | Genentech Inc | DcR3 polypeptid, en TNFR-homolog |
AU739304B2 (en) * | 1997-09-24 | 2001-10-11 | Sankyo Company Limited | Method of diagnosing metabolic bone diseases |
US6087555A (en) * | 1997-10-15 | 2000-07-11 | Amgen Inc. | Mice lacking expression of osteoprotegerin |
JPH11155420A (ja) * | 1997-12-02 | 1999-06-15 | Snow Brand Milk Prod Co Ltd | トランスジェニック動物 |
WO1999031128A2 (en) * | 1997-12-16 | 1999-06-24 | Incyte Pharmaceuticals, Inc. | Human tumor necrosis factor-r2-like proteins |
US6077689A (en) | 1997-12-24 | 2000-06-20 | Amgen Inc. | Enhanced solubility of recombinant proteins |
WO1999041374A2 (en) * | 1998-02-17 | 1999-08-19 | Incyte Pharmaceuticals, Inc. | Human short-chain tnf-receptor family protein |
US6103472A (en) * | 1998-02-20 | 2000-08-15 | Amgen Inc. | Methods and compositions for identifying novel secreted mammalian polypeptides in yeast |
US6150098A (en) * | 1998-02-20 | 2000-11-21 | Amgen Inc. | Methods for identifying novel secreted mammalian polypeptides |
ATE417068T1 (de) | 1998-04-23 | 2008-12-15 | Ajinomoto Kk | Stoff mit antithrombotischer aktivität und verfahren zur bestimmung von glycokallidin |
US6790823B1 (en) * | 1998-04-23 | 2004-09-14 | Amgen Inc. | Compositions and methods for the prevention and treatment of cardiovascular diseases |
AU762574B2 (en) | 1998-05-14 | 2003-06-26 | Immunex Corporation | Method of inhibiting osteoclast activity |
US6210924B1 (en) | 1998-08-11 | 2001-04-03 | Amgen Inc. | Overexpressing cyclin D 1 in a eukaryotic cell line |
CN1318105A (zh) * | 1998-09-15 | 2001-10-17 | M&E生物技术公司 | 负调节Osteoprotegerin配体活性的方法 |
US6420339B1 (en) | 1998-10-14 | 2002-07-16 | Amgen Inc. | Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility |
HU228582B1 (en) | 1998-10-23 | 2013-04-29 | Kirin Amgen Inc | Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity |
US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
US7488590B2 (en) | 1998-10-23 | 2009-02-10 | Amgen Inc. | Modified peptides as therapeutic agents |
NZ511506A (en) * | 1998-10-28 | 2004-02-27 | Sankyo Co | Remedies for bone metabolic errors comprising OCIF |
US6245740B1 (en) | 1998-12-23 | 2001-06-12 | Amgen Inc. | Polyol:oil suspensions for the sustained release of proteins |
JP2005517379A (ja) * | 1999-01-18 | 2005-06-16 | オステオミーター・ビオテク・エー/エス | 遺伝的疾病素因 |
US20030007972A1 (en) * | 1999-02-24 | 2003-01-09 | Edward Tobinick | Cytokine antagonists and other biologics for the treatment of bone metastases |
US7259253B2 (en) * | 1999-05-14 | 2007-08-21 | Quark Biotech, Inc. | Genes associated with mechanical stress, expression products therefrom, and uses thereof |
AU6078500A (en) * | 1999-07-09 | 2001-01-30 | Amgen, Inc. | Combination therapy for conditions leading to bone loss |
AUPQ167599A0 (en) * | 1999-07-19 | 1999-08-12 | St. Vincent's Institute Of Medical Research | Inhibitor of osteoclast precursor formation |
IL130989A0 (en) * | 1999-07-20 | 2001-01-28 | Compugen Ltd | Variants of alternative splicing |
US6673771B1 (en) | 1999-07-28 | 2004-01-06 | The Trustees Of The University Of Pennsylvania | Methods of inhibiting osteoclast activity |
US8106098B2 (en) | 1999-08-09 | 2012-01-31 | The General Hospital Corporation | Protein conjugates with a water-soluble biocompatible, biodegradable polymer |
AU6946300A (en) * | 1999-08-30 | 2001-03-26 | Mayo Foundation For Medical Education And Research | Use of dna encoding osteoprotegerin to prevent or inhibit metabolic bone disorders |
AU2005237128B2 (en) * | 1999-09-03 | 2008-09-11 | Amgen Inc. | Compositions and Methods for the Prevention or Treatment of Cancer and Bone Loss Associated with Cancer |
US20030144187A1 (en) * | 1999-09-03 | 2003-07-31 | Colin R. Dunstan | Opg fusion protein compositions and methods |
KR20010085996A (ko) * | 1999-09-03 | 2001-09-07 | 스티븐 엠. 오드레 | 암 및 암관련 골손실을 예방 또는 치료하는 조성물 및 방법 |
US6808902B1 (en) * | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
EP1238077A1 (en) * | 1999-12-16 | 2002-09-11 | Amgen Inc., | Tnfr/opg-like molecules and uses thereof |
US20030103978A1 (en) * | 2000-02-23 | 2003-06-05 | Amgen Inc. | Selective binding agents of osteoprotegerin binding protein |
ES2391124T3 (es) | 2000-06-28 | 2012-11-21 | Amgen Inc. | Moléculas de receptor de linfopoyetina estromal tímica y usos de las mismas |
DE01973455T1 (de) * | 2000-09-22 | 2004-04-22 | Immunex Corp., Seattle | Screeningverfahren für agonisten und antagonisten des rezeptoraktivators von nf-kappa b |
AU2002231602A1 (en) * | 2001-02-09 | 2002-08-28 | Maxygen Holdings Ltd. | Rank ligand-binding polypeptides |
ES2337716T3 (es) | 2001-04-03 | 2010-04-28 | Societe Des Produits Nestle S.A. | Osteoprotegerina en la leche. |
JP2005515159A (ja) * | 2001-06-06 | 2005-05-26 | イミュネックス・コーポレーション | 癌を治療するためのrankアンタゴニストの使用 |
YU103003A (sh) | 2001-06-26 | 2006-05-25 | Abgenix Inc. | Antitela za opgl |
EP1270015A3 (en) * | 2001-06-29 | 2004-02-25 | Sankyo Company Limited | A complex comprising OCIF and Polysaccharide |
KR100427299B1 (ko) * | 2001-08-10 | 2004-04-14 | 한국생명공학연구원 | 인체 골 재흡수 억제인자(hOPG)를 생산하는 재조합플라스미드 pGHOPG(KCTC 1019BP) |
US20030049694A1 (en) * | 2001-09-10 | 2003-03-13 | Chung-Hsiun Wu | Production of fusion proteins and use for identifying binding molecules |
US6800462B2 (en) * | 2001-09-10 | 2004-10-05 | Abgenomics Corporation | Production of recombinant proteins in vivo and use for generating antibodies |
US7521053B2 (en) | 2001-10-11 | 2009-04-21 | Amgen Inc. | Angiopoietin-2 specific binding agents |
US7205275B2 (en) | 2001-10-11 | 2007-04-17 | Amgen Inc. | Methods of treatment using specific binding agents of human angiopoietin-2 |
US7138370B2 (en) | 2001-10-11 | 2006-11-21 | Amgen Inc. | Specific binding agents of human angiopoietin-2 |
JP4336467B2 (ja) * | 2001-10-15 | 2009-09-30 | 株式会社林原生物化学研究所 | 破骨細胞形成抑制因子の産生を調節し得る物質のスクリーニング方法 |
US20030191056A1 (en) | 2002-04-04 | 2003-10-09 | Kenneth Walker | Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins |
MXPA04009681A (es) | 2002-04-05 | 2005-01-11 | Amgen Inc | Anticuerpos humanos neutralizantes anti-ligando de osteoprotegerina como inhibidores selectivos de la ruta del ligando de osteoprotegerina. |
US20080249068A1 (en) * | 2002-09-05 | 2008-10-09 | Deluca Hector F | Method of Extending the Dose Range of Vitamin D Compounds |
US7259143B2 (en) * | 2002-09-05 | 2007-08-21 | Wisconsin Alumni Research Foundation | Method of extending the dose range of vitamin D compounds |
AU2003297833A1 (en) | 2002-12-10 | 2004-06-30 | Schering-Plough Ltd. | Canine rankl and methods for preparing and using the same |
TWI293882B (en) | 2003-03-24 | 2008-03-01 | Sankyo Co | Polymeric modifiers and pharmaceutical compositions |
US8143380B2 (en) | 2004-07-08 | 2012-03-27 | Amgen Inc. | Therapeutic peptides |
ZA200704473B (en) * | 2004-12-13 | 2008-09-25 | Evogenix Ltd | Osteoprotegerin variant proteins |
US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
US9283260B2 (en) | 2006-04-21 | 2016-03-15 | Amgen Inc. | Lyophilized therapeutic peptibody formulations |
CA2687141C (en) | 2007-05-22 | 2014-04-01 | Amgen Inc. | Compositions and methods for producing bioactive fusion proteins |
EP2464377B1 (en) | 2009-08-14 | 2016-07-27 | The Government of the United States of America as represented by The Secretary of the Department of Health and Human Services | Use of il-15 to increase thymic output and to treat lymphopenia |
PT2621519T (pt) | 2010-09-28 | 2017-10-04 | Aegerion Pharmaceuticals Inc | Polipéptido de fusão de leptina-abd com duração de ação melhorada |
US9812699B2 (en) | 2011-10-05 | 2017-11-07 | Oned Material Llc | Silicon nanostructure active materials for lithium ion batteries and processes, compositions, components and devices related thereto |
EA034861B1 (ru) * | 2012-03-31 | 2020-03-30 | Р-Фарм Интернешнл, Ооо (Общество С Ограниченной Ответственностью) | Композиция, полученная из остеопротегерина, и способ ее использования |
EP3574017A1 (en) | 2017-01-27 | 2019-12-04 | Kymab Limited | Anti-opg antibodies |
JP6550413B2 (ja) * | 2017-02-24 | 2019-07-24 | アール−ファーム・インターナショナル・リミテッド・ライアビリティ・カンパニーR−Pharm International, Llc | オステオプロテゲリン由来の組成物およびその使用 |
CN111004318B (zh) * | 2019-12-30 | 2022-03-04 | 北京博康健基因科技有限公司 | rhPTH(1-34)蛋白原液的纯化方法 |
TW202203964A (zh) | 2020-04-17 | 2022-02-01 | 小利蘭史丹佛大學董事會 | 用於生物醫藥調配物之聚合物賦形劑 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US6936694B1 (en) | 1982-05-06 | 2005-08-30 | Intermune, Inc. | Manufacture and expression of large structural genes |
US4710473A (en) | 1983-08-10 | 1987-12-01 | Amgen, Inc. | DNA plasmids |
FR2640537B1 (fr) | 1988-12-21 | 1992-02-21 | Levy Guy | Installation et procede utilisant l'effet laser, pour la coupe ou la vaporisation de materiaux et tissus divers |
ATE135370T1 (de) | 1988-12-22 | 1996-03-15 | Kirin Amgen Inc | Chemisch modifizierte granulocytenkolonie erregender faktor |
AU648505B2 (en) | 1989-05-19 | 1994-04-28 | Amgen, Inc. | Metalloproteinase inhibitor |
US5395760A (en) * | 1989-09-05 | 1995-03-07 | Immunex Corporation | DNA encoding tumor necrosis factor-α and -β receptors |
US5118667A (en) * | 1991-05-03 | 1992-06-02 | Celtrix Pharmaceuticals, Inc. | Bone growth factors and inhibitors of bone resorption for promoting bone formation |
CA2068389A1 (en) * | 1991-05-13 | 1992-11-14 | Masahiko Sato | Method for inhibiting bone resorption |
US5447851B1 (en) | 1992-04-02 | 1999-07-06 | Univ Texas System Board Of | Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells |
JP3284481B2 (ja) | 1993-08-20 | 2002-05-20 | 本田技研工業株式会社 | 車両用油圧作動式変速機の油圧制御回路 |
US6268212B1 (en) | 1993-10-18 | 2001-07-31 | Amgen Inc. | Tissue specific transgene expression |
JP3433495B2 (ja) | 1993-12-30 | 2003-08-04 | カシオ計算機株式会社 | 表示制御装置および表示制御方法 |
US6309853B1 (en) * | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
IL117175A (en) | 1995-02-20 | 2005-11-20 | Sankyo Co | Osteoclastogenesis inhibitory factor protein |
WO1996028546A1 (en) | 1995-03-15 | 1996-09-19 | Human Genome Sciences, Inc. | Human tumor necrosis factor receptor |
US8615703B2 (en) | 2010-06-04 | 2013-12-24 | Micron Technology, Inc. | Advanced bitwise operations and apparatus in a multi-level system with nonvolatile memory |
-
1996
- 1996-09-03 US US08/706,945 patent/US6369027B1/en not_active Expired - Fee Related
- 1996-12-19 AR ARP960105797A patent/AR004400A1/es unknown
- 1996-12-20 AU AU14686/97A patent/AU710587B2/en not_active Ceased
- 1996-12-20 MX MX9706193A patent/MX9706193A/es not_active IP Right Cessation
- 1996-12-20 SI SI9630764T patent/SI0784093T1/sl unknown
- 1996-12-20 PL PL96321938A patent/PL187408B1/pl not_active IP Right Cessation
- 1996-12-20 JP JP52386197A patent/JP4657388B2/ja not_active Expired - Fee Related
- 1996-12-20 PT PT96309363T patent/PT784093E/pt unknown
- 1996-12-20 GB GB9626618A patent/GB2312899B/en not_active Expired - Fee Related
- 1996-12-20 YU YU69196A patent/YU69196A/sr unknown
- 1996-12-20 EP EP08003204A patent/EP1990415A1/en not_active Withdrawn
- 1996-12-20 WO PCT/US1996/020621 patent/WO1997023614A1/en active Application Filing
- 1996-12-20 EP EP10181616A patent/EP2332974A3/en not_active Withdrawn
- 1996-12-20 TR TR96/01036A patent/TR199601036A2/xx unknown
- 1996-12-20 NZ NZ332915A patent/NZ332915A/xx unknown
- 1996-12-20 CZ CZ19972538A patent/CZ292587B6/cs not_active IP Right Cessation
- 1996-12-20 HU HU9801122A patent/HU227482B1/hu not_active IP Right Cessation
- 1996-12-20 FR FR9615707A patent/FR2742767B1/fr not_active Expired - Fee Related
- 1996-12-20 CN CNB961934417A patent/CN1318588C/zh not_active Expired - Fee Related
- 1996-12-20 RO RO97-01539A patent/RO121386B1/ro unknown
- 1996-12-20 AT AT96309363T patent/ATE409745T1/de active
- 1996-12-20 DK DK96309363T patent/DK0784093T3/da active
- 1996-12-20 DE DE19654610A patent/DE19654610A1/de not_active Ceased
- 1996-12-20 NZ NZ326579A patent/NZ326579A/xx unknown
- 1996-12-20 ES ES96309363T patent/ES2316152T3/es not_active Expired - Lifetime
- 1996-12-20 SK SK1107-97A patent/SK110797A3/sk not_active Application Discontinuation
- 1996-12-20 KR KR1019970705843A patent/KR100463584B1/ko not_active IP Right Cessation
- 1996-12-20 CA CA2210467A patent/CA2210467C/en not_active Expired - Fee Related
- 1996-12-20 EP EP96945279A patent/EP0870023A1/en not_active Withdrawn
- 1996-12-20 EP EP96309363A patent/EP0784093B1/en not_active Expired - Lifetime
- 1996-12-20 EE EE9700164A patent/EE04643B1/xx not_active IP Right Cessation
-
1997
- 1997-08-05 BG BG101813A patent/BG63347B1/bg unknown
- 1997-08-11 IL IL121520A patent/IL121520A/en not_active IP Right Cessation
- 1997-08-12 NO NO973699A patent/NO973699L/no not_active Application Discontinuation
-
1998
- 1998-01-16 HK HK98100367A patent/HK1001526A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69637695D1 (de) | Osteoprotegerin | |
DK0784093T3 (da) | Osteoprotegerin | |
ATA135896A (de) | Skibob | |
NO964334D0 (no) | Sulfonylaminopyrimidiner | |
ATE198470T1 (de) | Alkenyl-benzoylguanidine | |
ATE240972T1 (de) | Cyclopeptolide | |
ATA119896A (de) | Scheibenmähwerk | |
ID17460A (id) | Osteoprotegerin | |
SE9501817D0 (sv) | När/långsyntssimdykningsglasögon | |
KR960028533U (ko) | "t" 자 | |
SE9501165D0 (sv) | Hållaranordning | |
BR7501836U (pt) | Protecheque | |
BR7501299U (pt) | Geladeira-prática | |
BR7502653U (pt) | Publi-taxi | |
BR7502098U (pt) | T-compacto | |
BR7502025U (pt) | Kantil | |
BR7501939U (pt) | Caixa-ambalgem | |
BR7501858U (pt) | Tellelight | |
BR7502853U (pt) | Faixa-surf | |
BR7501828U (pt) | Multicopo | |
BR7501485U (pt) | Fibropiso | |
BR7501467U (pt) | Vassourágua | |
BR7501437U (pt) | Leiteira | |
BR7501426U (pt) | Búlica | |
BR7501399U (pt) | Ciclonavegador |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HD1A | Correction of address | ||
KB4A | Valid patent at the end of a year |
Effective date: 20061231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20071231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20101231 |
|
MM4A | Lapsed by not paying the annual fees |
Effective date: 20131220 |